OxFORD Asset Management LLP Takes Position in Quidel Corporation (QDEL)
OxFORD Asset Management LLP purchased a new position in Quidel Corporation (NASDAQ:QDEL) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 94,773 shares of the company’s stock, valued at approximately $2,572,000. OxFORD Asset Management LLP owned 0.28% of Quidel Corporation at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. SG Americas Securities LLC grew its holdings in Quidel Corporation by 8.1% in the second quarter. SG Americas Securities LLC now owns 38,347 shares of the company’s stock worth $1,041,000 after purchasing an additional 2,871 shares during the period. Legal & General Group Plc grew its holdings in Quidel Corporation by 4.6% in the first quarter. Legal & General Group Plc now owns 6,931 shares of the company’s stock worth $157,000 after purchasing an additional 306 shares during the period. Trellus Management Company LLC grew its holdings in Quidel Corporation by 98.0% in the second quarter. Trellus Management Company LLC now owns 22,930 shares of the company’s stock worth $622,000 after purchasing an additional 11,350 shares during the period. Eagle Boston Investment Management Inc. grew its holdings in Quidel Corporation by 3.4% in the second quarter. Eagle Boston Investment Management Inc. now owns 359,034 shares of the company’s stock worth $9,744,000 after purchasing an additional 11,890 shares during the period. Finally, Macquarie Group Ltd. grew its holdings in Quidel Corporation by 23.6% in the first quarter. Macquarie Group Ltd. now owns 1,195,927 shares of the company’s stock worth $27,076,000 after purchasing an additional 228,515 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.
Quidel Corporation (QDEL) opened at 43.15 on Thursday. The firm has a 50 day moving average of $37.81 and a 200-day moving average of $29.52. The company’s market capitalization is $1.44 billion. Quidel Corporation has a 1-year low of $18.25 and a 1-year high of $45.55.
Quidel Corporation (NASDAQ:QDEL) last issued its quarterly earnings data on Wednesday, July 26th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.17) by ($0.18). The company had revenue of $38.30 million for the quarter, compared to analysts’ expectations of $41.91 million. Quidel Corporation had a negative net margin of 0.03% and a negative return on equity of 0.03%. The firm’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.11) earnings per share. On average, equities research analysts anticipate that Quidel Corporation will post $0.29 earnings per share for the current fiscal year.
In other news, CFO Randall J. Steward sold 94,215 shares of the company’s stock in a transaction dated Friday, July 28th. The shares were sold at an average price of $34.09, for a total value of $3,211,789.35. Following the sale, the chief financial officer now directly owns 79,907 shares of the company’s stock, valued at approximately $2,724,029.63. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Douglas C. Bryant sold 12,000 shares of the company’s stock in a transaction dated Wednesday, September 27th. The stock was sold at an average price of $42.17, for a total transaction of $506,040.00. Following the completion of the sale, the chief executive officer now directly owns 296,493 shares in the company, valued at $12,503,109.81. The disclosure for this sale can be found here. Insiders sold a total of 227,388 shares of company stock worth $8,274,312 over the last ninety days. Insiders own 22.00% of the company’s stock.
A number of research firms have commented on QDEL. Barclays PLC raised their price target on shares of Quidel Corporation from $36.00 to $39.00 and gave the stock an “overweight” rating in a report on Thursday, July 27th. BidaskClub cut shares of Quidel Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Piper Jaffray Companies upgraded shares of Quidel Corporation from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $35.00 to $50.00 in a report on Tuesday, September 19th. Canaccord Genuity restated a “buy” rating and issued a $48.00 price target (up from $42.00) on shares of Quidel Corporation in a report on Tuesday, September 19th. Finally, Raymond James Financial, Inc. raised their price target on shares of Quidel Corporation from $36.00 to $41.00 and gave the stock an “outperform” rating in a report on Thursday, July 27th. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Quidel Corporation presently has a consensus rating of “Buy” and an average target price of $44.00.
About Quidel Corporation
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.
Want to see what other hedge funds are holding QDEL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quidel Corporation (NASDAQ:QDEL).
Receive News & Ratings for Quidel Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.